Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LifeCodexx's PraenaTest Express; Multiplicom's Mutation Detection Kits

Premium

GATC Biotech subsidiary LifeCodexx has launched a new version of its noninvasive fetal aneuploidy test, PraenaTest Express, that has a turnaround time of one week. The express version of the test will initially be available in Germany, and after a pilot phase will be introduced in other European countries, according to the company.


Multiplicom had launched three mutation-detection kits based on the company's proprietary MASTR technology. The three kits, which detect mutations common in gastrointestinal track, colon, lung, and skin cancers, can be used in combination with all next-gen sequencing systems.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.